4.7 Review

New strategies to treat AML: novel insights into AML survival pathways and combination therapies

Journal

LEUKEMIA
Volume 35, Issue 2, Pages 299-311

Publisher

SPRINGERNATURE
DOI: 10.1038/s41375-020-01069-1

Keywords

-

Funding

  1. Wilhelm-Sander Stiftung [2017.122.1]
  2. graduate program Infection Research on Human Pathogens@MvPI at Max von Pettenkofer Institute, LMU
  3. Max WeberProgram of the State of Bavaria
  4. Projekt DEAL

Ask authors/readers for more resources

The treatment of acute myeloid leukemia (AML) is challenging due to its heterogeneity, leading to a shift towards personalized treatment based on genomic signature. Novel insights into AML survival pathways, including drug resistance and immune system evasion, are being revealed. The combination of drugs or treatments has shown enhanced clinical efficiencies, prompting further investigation into targeted pathways for increased treatment response.
The effective treatment of acute myeloid leukemia (AML) is very challenging. Due to the immense heterogeneity of this disease, treating it using a one size fits all approach is ineffective and only benefits a subset of patients. Instead, there is a shift towards more personalized treatment based on the patients' genomic signature. This shift has facilitated the increased revelation of novel insights into pathways that lead to the survival and propagation of AML cells. These AML survival pathways are involved in drug resistance, evasion of the immune system, reprogramming metabolism, and impairing differentiation. In addition, based on the reports of enhanced clinical efficiencies when combining drugs or treatments, deeper investigation into possible pathways, which can be targeted together to increase treatment response in a wider group of patients, is warranted. In this review, not only is a comprehensive summary of targets involved in these pathways provided, but also insights into the potential of targeting these molecules in combination therapy will be discussed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available